•   South Central Asia
  • Sustainability
  • Careers
  • Search

Solution for Mastitis (SCC), Immunity, Lameness, Enriched milk.

Mastitis is one of the costliest health problems of dairy cattle and is a major source of economic loss to dairy farmers. Somatic cell count (SCC) in milk is one of the best indicators of udder health status both in pathogenic and non-pathogenic cases.

It results in a significant reduction in milk yield, due to damage of milk producing tissues in the udder. The somatic cell count is the number of cells present in milk (body cells as distinguished from invading bacterial cells). It is used as an indicator of udder infection. Somatic cell counts higher than 283,000 cells/ ml indicate the presence of mastitis (Reneau, 1986).

Udder health & Mineral Nutrition:

Adequate mineral nutrition may be used as a strategy to optimize immune system function by the reduction of metabolic and oxidative stress; and therefore it may have a positive effect on the defense mechanisms of the mammary gland against mastitis(Weiss and Wyatt, 2002).

b0277081-72fd-446c-989f-efeac035c35c Maintains skin integrity and the keratin lining of the teat canal promotes wound healing, improves immunity.

5a39ca51-da74-4068-9742-e673826986e2 Connective tissue formation helps to reduce E.Coli mastitis.

ff637e9a-36d1-40d6-a67c-c87827c6e766 Formation of collagen tissue & promotes wound healing

98465b15-5f93-4d70-bf94-506d810fea57 Methionine source, rumen-active component

Novus provides MINTREX® chelated trace minerals, a highly bioavailable source of zinc, copper, and manganese.

Mintrex Zn has reduced 55% SCC in 28 Days

TRIAL RESULTS : Objective and protocol

  • Study of Mintrex Zn on SCC in CMT-positive animals.
  • Study duration - 28 days.
  • No of animals - 30 (HF X and Jersey X) with less than 100 DIM positive for CMTwere selected.
  • Dose 2.Sg/h/d.
  • SCC, Milk yield, FAT, and SNF were tested for the treated animals ondays0,3,7,14, and 28.

423a5fbb-8558-4855-a381-f350b649f3e9

3b40188c-2434-401a-bfcb-abcf0a54a432

d170dc19-79ac-4851-9f8e-cb112fb777ac

af288d73-a363-446b-af35-b601b3024b35

Want to know more?

For additional information and trial data, please fill the form below